The Clorox Company (NYSE:CLX) Shares Sold by Trust Co. of Toledo NA OH

Trust Co. of Toledo NA OH cut its holdings in shares of The Clorox Company (NYSE:CLX) by 7.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,474 shares of the company’s stock after selling 113 shares during the period. Trust Co. of Toledo NA OH’s holdings in Clorox were worth $239,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Prospera Private Wealth LLC acquired a new stake in Clorox during the third quarter valued at approximately $27,000. Continuum Advisory LLC lifted its stake in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares during the last quarter. Quarry LP lifted its stake in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Carolina Wealth Advisors LLC acquired a new stake in Clorox during the third quarter valued at approximately $48,000. Finally, Friedenthal Financial acquired a new stake in Clorox during the third quarter valued at approximately $49,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of CLX opened at $157.32 on Tuesday. The company’s fifty day moving average is $164.55 and its 200-day moving average is $156.00. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The firm has a market cap of $19.47 billion, a price-to-earnings ratio of 54.82, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the business posted $0.49 EPS. Clorox’s quarterly revenue was up 27.0% on a year-over-year basis. Equities analysts expect that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.10%. Clorox’s dividend payout ratio (DPR) is 170.03%.

Analysts Set New Price Targets

Several brokerages recently commented on CLX. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $155.00 to $157.00 in a research report on Tuesday, January 7th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Barclays upped their price target on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st. Finally, JPMorgan Chase & Co. upped their price target on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $157.46.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.